The Value Map and the Value-Equivalence Line: Where Share Comes From

The value map is one of the most-used diagnostic tools in commercial pricing. Despite often being called "Nagle's value map" in working circles, the framework was originated by Ralf Leszinski and Michael Marn in The McKinsey Quarterly article "Setting Value, Not Price" (1997). Nagle, Hogan & Zale's The Strategy and Tactics of Pricing adopted and popularised the framework in the academic textbook treatment, which is why it carries Nagle's name in working circles. Both attributions are common; only McKinsey 1997 is the original publication.

The map is a two-dimensional plot:
- Vertical axis: perceived price. Not list price, not cost. What the buyer perceives they are paying when they choose between competing products.
- Horizontal axis: perceived benefits. A composite of the functional, emotional, and brand-associated benefits the buyer perceives the product delivers, scored on a comparable scale across the competitive set.

The diagonal line that bisects the chart is the value-equivalence line (VEL). It is the locus of points where price and benefits trade off in balance. Every position on the line represents a "fair" price for the level of benefits offered, given the competitive set.

Where a product lands relative to the VEL is the structural reason it is gaining or losing share.

• To the right of the line = value advantaged. The buyer perceives more benefit than the price suggests they should be paying. Practitioner literature also calls these "share gainers".
• To the left of the line = value disadvantaged. The buyer perceives less benefit than the price suggests. Also called "share losers".

Two zones, one line. The map is most useful when it is built from real consumer perception data (a perceived-benefits scoring exercise across the buying audience), not from internal team intuition. Internal teams almost always overestimate their own product's perceived benefits and underestimate competitors'.

Three quantitative steps build a working value map.

Step 1, score perceived benefits.
For each competitor in the set, score the perceived benefits on a comparable scale. A common approach is a 1-to-10 weighted score across 5 to 8 attributes that the target consumer cares about most. The scores must come from buyers, not from the internal team.

Composite Benefit Score = Σ (Attribute Importance × Attribute Performance) for each competitor

Step 2, plot.
Place each competitor on the chart. X-axis: composite benefit score. Y-axis: perceived price (typically the price the buyer expects to pay, not the headline list price).

Step 3, draw the value-equivalence line.
The VEL passes through the average price-benefits position of the category. It is the line of best fit through the cluster of competitors who are roughly holding share. Mathematically, it is the regression of price on benefits across the competitive set.

VEL slope = ΔPerceived Price / ΔBenefits Score

The slope is the implicit "price per benefit unit" the category accepts as fair. In a price-led category (private label sets the floor), the slope is shallow. In a benefits-led category (premium brands lead), the slope is steep.

Reading the result.
Distance from the VEL is the diagnostic number. A product five units to the right of the VEL is gaining share. A product five units to the left is losing share. The sign of the distance tells you direction. The magnitude tells you how aggressively share is moving.

A frozen-pizza brand sits at perceived price index 105 (5 percent above category average) and benefits score 55 out of 100. The category VEL passes through (50, 100): the average competitor is at 50 benefits, 100 perceived price, holding share.

The brand's position implies it should be slightly to the right of the VEL, given its higher-than-average benefits. Mapping the current benefits score (55) against the VEL slope shows the value-equivalent price for those benefits is index 110. The brand is at 105.

Reading: the brand is value advantaged by 5 perceived-price points, which explains its 0.5 share-point gain over the last 6 months. The buyer perceives more benefit at 105 than the average competitor delivers at the same price.

Three follow-up moves a cascade-aware practitioner now considers.

Option A, capture the value gap with a price rise. Move from 105 to 110. The brand lands on the VEL. Share growth pauses. Margin improves by roughly 4.7 percent. Best move when the team is funding inflation and willing to give up the share gain.

Option B, capture the gap with a benefits push. Hold price at 105 and improve benefits score from 55 to 60 (a feature upgrade, a renovation, a pack improvement). The brand stays value advantaged at the new benefits level. Share gain accelerates. Margin holds.

Option C, use the cushion to fund a launch. Hold price and benefits as-is. Use the 5-point cushion as protection against a premium SKU launch that would otherwise risk repositioning the brand into the disadvantaged zone. Net new revenue from launch, no risk to share gain.

The value map made the trade-off visible in one chart. Without the map, the team's likely default would be Option A (a price rise, because inflation), giving up the share gain that was the brand's real source of value.

Three day-to-day uses, in roughly increasing order of strategic ambition.

Use 1, diagnostic. Plot the current competitive set. Where does each product land relative to the VEL? Products on the right are taking share from products on the left, and the brand should be able to predict next quarter's share movement from the chart alone.

Use 2, move planning. A planned price increase moves the brand vertically up the chart. Does the move take it off the VEL into the value-disadvantaged zone? If yes, the price increase needs to be paired with a benefits move (a feature improvement, a pack upgrade, a claim refresh) to restore VEL position. The map turns "price increase versus volume loss" into a structural question rather than a simple elasticity calculation.

Use 3, repositioning. A planned premium launch needs to land in the value-advantaged zone (right of the VEL) to gain share. The map exists to answer "is the gap between perceived benefits and perceived price wide enough?" before launch, not after.

Three things the map does not do.

It does not measure absolute willingness to pay. The VEL gives relative position within a competitive set. For absolute price-acceptance, pair with a Van Westendorp PSM or a Gabor-Granger test.

It does not predict private-label disruption that re-sets the entire category VEL. A category VEL drawn at a moment in time can be redrawn six months later by a meaningful private-label entry that shifts the category benefits-floor.

It does not replace primary research. The benefits-axis score has to come from buyers. An internally-produced map is almost always wrong on the benefits axis and produces false reassurance.